Loading company…
TreatGut, established in 2016 and headquartered in Shanghai, China, develops microbiome transplantation therapies and testing equipment.
Established in 2016 and based in Guangzhou, China, TreatGut is a biopharmaceutical and equipment developer focused on microbiome transplantation therapies. It is headquartered in Shanghai, with R&D bases in Xiamen and Singapore and subsidiaries in several Chinese cities. Its products include microbiome analysis and transplantation services, colony, intestinal and fecal testing equipment, and health products. In June 2025 the company received a strategic investment led by new investor Jinyuan Kuntong Equity Investment Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in